Real-World Evidence Gathering in Oncology: The Need for a Biomedical Big Data Insight-Providing Federated Network
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference16 articles.
1. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients;Eichler;Clin Pharmacol Ther,2015
2. Assessing the value of cancer treatments from real world data—Issues, empirical examples and lessons learnt;Moen;J Cancer Policy,2017
3. Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden;Ferrario;Soc Sci Med,2015
4. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR-ISPE special task force on real-world evidence in health care decision making;Berger;Value Health,2017
5. Visualizing data for hypothesis generation using large-volume claims data;Onukwugha;Value Outcomes Spotlight,2017
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bridging Data Silos in Oncology with Modular Software for Federated Analysis on FHIR: A Multisite Implementation Study (Preprint);2024-08-22
2. The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial;Clinical Trials;2023-07-25
3. A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data;Future Oncology;2023-01
4. Haematology Outcomes Network in Europe ( HONEUR )—A collaborative, interdisciplinary platform to harness the potential of real‐world data in hematology;European Journal of Haematology;2022-05-14
5. A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges;Frontiers in Pharmacology;2021-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3